Abstract
Purpose: To investigate the correlation between several lipid-lowering and hypoglycemic drugs and the risk of gastric cancer (GC) in elderly population.Methods: A total of 160 elderly patients with GC who attended The First Affiliated Hospital of Henan University of Science and Technology from January 1, 2014 to December 31, 2020 were enrolled in the study group. Furthermore, 320 healthy volunteers within the same period were assigned to the control group. Clinical data (such as history of statin, sulfonylurea and biguanide administration) were collected from the patient’s medical records. Multifactorial logistic regression was used to determine the association between these lipid-lowering and glucose-lowering drugs, and the risk of developing GC.Results: After adjusting for numerous confounding factors, multifactorial logistic regression showed that long-term use (>12 months of treatment) of statins and biguanides significantly reduced the risk of GC in elderly population (p = 0.006, p = 0.004, respectively), while long-term use of sulphonylureas increased the risk of GC in elderly population (p = 0.004).Conclusion: Statins, sulfonylureas and biguanides may be closely associated with the development of GC in elderly population. Therefore, a detailed understanding of the efficacy and mechanisms of action of these drugs may benefit the elderly in the prevention and control of GC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
